Geographic · Property, plant and equipment, net

Rest of world — Property, plant and equipment, net

Moderna Rest of world — Property, plant and equipment, net decreased by 4.7% to $363.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.7%, from $381.00M to $363.00M.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2021
Last reportedQ4 2025Feb 20, 2026
Rolls up toPP&E (Net)

How to read this metric

An increase suggests significant capital investment in international infrastructure to support future growth, while a decrease may indicate asset divestment or a shift toward outsourced manufacturing models.

Detailed definition

This metric measures the net book value of tangible assets, such as manufacturing facilities, laboratories, and speciali...

Peer comparison

Large-cap pharmaceutical companies often disclose regional asset bases to highlight their global manufacturing capacity and supply chain resilience.

Metric ID: mrna_segment_rest_of_world_property_plant_and_equipment_net

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$10.00M$37.00M$259.00M$381.00M$363.00M
QoQ Change+270.0%+600.0%+47.1%-4.7%
YoY Change+270.0%+600.0%+47.1%-4.7%
Range$10.00M$381.00M
CAGR>999%
Avg YoY Growth+228.1%
Median YoY Growth+158.6%

Frequently Asked Questions

What is Moderna's rest of world — property, plant and equipment, net?
Moderna (MRNA) reported rest of world — property, plant and equipment, net of $363.00M in Q4 2025.
How has Moderna's rest of world — property, plant and equipment, net changed year-over-year?
Moderna's rest of world — property, plant and equipment, net decreased by 4.7% year-over-year, from $381.00M to $363.00M.
What does rest of world — property, plant and equipment, net mean?
The net value of physical assets and infrastructure owned by the company in international locations.